Back

Myeloperoxidase as a biomarker for anticipating STEMI in individuals with atrial fibrillation.

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Coronary artery disease / chronic coronary syndromes 1 Revascularisation HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

4 More presentations in this session

Presentation thumbnail
Impact of cancer history on non-ST-segment elevation myocardial infarction (NSTEMI) prognosis, a propensity-score matching (PSM) analysis
Doctor C. Oliveira Ferreira (Braga, PT)
Abstract Slides Video
Presentation thumbnail
Echocardiographic predictors for chronic coronary artery disease in patients with ST-T alterations
Associate Professor A. Bakalli (Pristina, XK)
Abstract Slides Video
Presentation thumbnail
Coronary artery aneurisms presenting as acute coronary syndrome: how should we best manage these patients?
Doctor A. Carvalho Santos (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Are we gender-biased in prescription practices?
Doctor C. Pereira Mateus (Amadora, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Coronary artery disease / chronic coronary syndromes 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources